Medicinova Inc. buy melinda
Start price
15.10.17
/
50%
€6.09
Target price
26.10.17
€6.31
Performance (%)
7.41%
End price
26.10.17
€6.54
Summary
This prediction ended on 26.10.17 with a price of €6.54. The BUY prediction by melinda finished with a performance of 7.41%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medicinova Inc. | - | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by melinda for this prediction
In the thread Medicinova Inc. diskutieren
Progredienter Multipler Sklerose (progressive MS)
Die erste Zeile der Daten aus dem Phase - 2b wird 28. Oktober präsentiert wird 2017 auf der gemeinsamen Sitzung ECTRIMS - ACTRIMS.
(Zielkurs erreicht)